51 F
New York
Tuesday, April 20, 2021

Moderna Inc. [NASDAQ: MRNA] Announces Modification To Its BARDA Agreement

Must read

IAA [NYSE: IAA] Announces Expansion of Delivery Services in the UK

IAA, Inc. disclosed that its UK-based business unit has decided to expand its vehicle delivery services for its buyers. This expansion decision has...

ICON [NASDAQ: ICLR] Secures Multiple Categories in 2021 CRO Leadership Awards

ICON Public Limited Company has disclosed that it has won multiple categories in the annual CRO Leadership Awards. This is another greatest achievement...

Equinox Announces Sale of Pilar Gold Mine

Equinox Gold Corp. revealed Monday that it has decided to sell its Pilar Gold Mine in Brazil to Pilar Gold Inc. The firm...

OpGen [NASDAQ: OPGN] Announces Strategic Collaboration New York State Department of Health

OpGen, Inc. revealed that it has entered into a strategic collaboration deal with the New York State Department of Health. The focus of...

Moderna Inc. [NASDAQ: MRNA] has announced Sunday that it has changed its contract with Biomedical Advanced Research and Development Authority (BARDA). According to the modification, it has received an additional commitment of $472 million to aid the late clinical-stage development including the expanded Phase 3 study of the company’s mRNA vaccine candidate (mRNA-1273) against COVID-19.

Earlier, BARDA has awarded up to $483 million to help the clinical development and mRNA-1273 with a small number of participants in phase 3 clinical trial. After consultation with the US Food and Drug Administration (FDA) and Operation Wrap Speed, Moderna Inc has decided to conduct a larger Phase 3 clinical trial.

After this modification in contract with BARDA the additional payment help company to conduct the phase 3 trial with 30,000 participants. The total investment from BARDA is now valued at $955 million.

Shares of Moderna Inc. dropped 2.81% during the trading of Friday. The company has a closing price of $73.21. It has a trading volume of 27.7 million as compared to the average volume of 25.91 million.

If we turn our focus on profitability, it has return on assets (ROA) of -29.20%, return on equity (ROE) of -37.40% and return on investment (ROI) of -44.90%. Looking at its liquidity, this company has a current and quick ration of 9.30.

In the past 52-weeks of trading, its stocks have oscillated between the low of $11.54 and a high of $95.21. It has moved up 534.40% from its 52-weeks low and moved down -23.11% from 52-weeks high. Moderna Inc has recorded the sales of 52.60 million and has a market cap of 29.21 billion.

Stéphane Bancel, Moderna’s Chief Executive Officer has expressed gratitude to BARDA for the support in the trial of the coronavirus vaccine candidates. Moderna Inc phase 3 COVE study will begin from tomorrow July 27 in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID).

FDA has checked the phase 3 stuy protocol and its process is same as according to the FDA guidance for COVID-19 vaccine. mRNA-1273 is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein. It was selected by Moderna Inc in collaboration with investigators from the VRC.

More articles

Latest article

Why Mer Telemanagement [NASDAQ: MTSL] Skyrocketed on Friday?

Shares of Mer Telemanagement Solutions Ltd skyrocketed during the trading session of Friday. The strong performance of the firm has indicated the positive...

Largo Resources Gets Approval for Listing on Nasdaq Stock Exchange

Largo Resources disclosed that it has finally obtained authorization from Nasdaq Stock Market LLC. As per the approval, the firm will now eligible to...

Aurora Mobile [NASDAQ: JG] Inks Agreement with Wanda Film

Aurora Mobile Limited disclosed Thursday that it has inked an agreement with Wanda Film Holding Co Ltd. Since its inception, Aurora Mobile has...

Brady [NYSE: BRC] Commence Tender Offer to Buy Nordic ID Oyj

Brady Corporation has inked an agreement with Nordic ID for its acquisition. The firm has commenced the tender offering to buy all the...

Cinedigm [NASDAQ: CIDM] Achieve Record Subscription and Ad-Supported User Growth Milestones

Shares of Cinedigm Corp. skyrocketed 19.30% after the firm reported the update about the subscription. The firm has achieved the best ever achievement...

Aurora Mobile [NASDAQ: JG] Signs Partnership Agreement with Yivi

Aurora Mobile Limited revealed that it has inked a collaboration deal with Hangzhou Yivi Intelligent Technology Co., LTD. (Yivi). Yivi and Aurora both...

Total [NYSE: TOT] Join Forces with Siemens Energy to Reduce LNG Related Emissions

Total SE has joined forces with Siemens Energy to explore the solution for the reduction of CO2 emissions. The firms have inked a...

Kaixin [NASDAQ: KXIN] Signs Cooperation Agreement with Jingdong

Kaixin Auto Holdings declared Monday that it has inked a deal with Jingdong Century Trade Limited. The agreement is the collaboration agreement between...